The biotechnology market comprises products like biologics, genetically engineered drugs, recombinant DNA technology, vaccines, tissue engineering, and cultured cells. Biologics have revolutionized modern medicine and provided therapeutic alternatives over chemically synthesized drugs due to their high target specificity, lower toxicity, and fewer side effects.
The Global Biotechnology Market is estimated to be valued at US$ 820.4 billion in 2023 and is expected to exhibit a CAGR of 12.3% over the forecast period 2023 to 2030.
Key Takeways
Key players operating in the biotechnology are Abbott Laboratories, Amgen Inc., GlaxoSmithKline, Johnson and Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Inc., Roche, and Sanofi – Aventis. Key players are investing heavily in R&D to develop novel and innovative biologic drugs for chronic diseases. For instance, AbbVie spent $5.4 billion on R&D for new biologic drugs in 2020.
The growing burden of chronic diseases and genetic disorders worldwide is driving the demand for biologic drugs in the market. Biologics have revolutionized the treatment of autoimmune diseases, cancer, cardiac diseases, and others. Their target specificity enables effective treatment with fewer side effects compared to traditional drugs.
Biotechnology Market Demand is expanding globally due to growing demand, increasing bio-pharma investments, and favorable policies supporting drug development. The Asia Pacific region is witnessing the fastest growth, driven by rising healthcare expenditure, rapid economic development, and the increasing penetration of health insurance in developing countries. China and India are emerging as new hubs for innovation and manufacturing, further boosting market.
Market Key Trends
Precision medicine using genetic sequencing and molecular profiling is a key trend in the biotechnology industry. It allows tailoring medical treatment - drugs, vaccinations or lifestyle recommendations -to the individual patient based on their genetic content or other molecular or cellular analysis. For instance, breast cancer genomic tests like Oncotype DX inform doctors about the likelihood of cancer recurrence in early-stage patients and thus optimize treatment approaches. Advancements in gene therapy and cell therapy are also gaining momentum to effectively treat previously untreatable diseases.
Porter’s Analysis
Threat of new entrants: High capital requirements for R&D activities and licensing make entry difficult for new players.
Bargaining power of buyers: Large pharmaceutical companies have strong buyer power due to their large scale of operations and ability to negotiate prices.
Bargaining power of suppliers: Suppliers of inputs like equipment and reagents have moderate bargaining power due suppliers have some product differentiation.
Threat of new substitutes: Threat is moderate as new biologics take time to develop and get regulatory approvals.
Competitive rivalry: Intense competition exists among existing players due to their large R&D investment and quest for new blockbuster products.
North America holds the largest share of the global biotechnology market, followed by Europe. This is attributed to favorable government funding, advanced healthcare infrastructure, presence of major players, and high adoption of biopharmaceuticals.
Asia Pacific region is expected to witness the fastest growth during the forecast period. This is attributed to increasing healthcare expenditure, rising disposable incomes, growing geriatric population, expanding research base and increasing strategic agreements between regional and global players. Countries such as China and India are likely to offer significant growth opportunities for market players in the coming years.
Get This Report in Japanese Language - バイオテクノロジー市場
Get This Report in Korean Language - 생명공학 시장
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
